Development code · Small Molecule
AGN-241660
AGN-241660 is a development code for Apimostinel (GATE-202), developed by Syndeio Biosciences, Inc..
- Status
- Phase 2 for Major depressive disorder
- Mechanism
- GluN2B PAM
- Developer
- Syndeio Biosciences, Inc.
Programs
- Apimostinel (GATE-202) for Major depressive disorderPhase 2Recruiting
Also known as
- Apimostinel
- GATE-202
- NRX-1074
- 1421866-48-9